Microbiology Testing Market Research Report—Global Forecast till 2027

Global Microbiology Testing Market: Information by Product Type (Consumables, Instruments), Type of Test (Bacterial, Viral, Fungal), Application (Gastrointestinal Infections, Respiratory Infections, Urinary Tract Infections, Sexually Transmitted Infection), End User (Hospital Assisted Laboratory, Independent Laboratory, Academic and Research Institutes), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027

ID: MRFR/HC/0226-CR | June, 2021 | Region : Global

Market Forecast

The global microbiology testing market is expected to cross USD 5409.1 6 Million by 2027 at a CAGR of 10.4%.  

Market Overview:

Microbiology testing is an analytical technique utilized to determine thenumber of microorganisms in biological samples, food, beverages, and environmental samples. The microbiology testing technique employs chemical, biological, biochemical, or molecular methods to identify and quantify microbes. The global microbiology testing market is mainly driven by the increasing number of infectious diseases and growing government and private funds and support for research and development. The rising number of product launches and approvals is also driving the growth of the market. However, factors such as unfavorable reimbursement scenarios and the accuracy of microbiology tests are expected to restrict the market growth during the forecast period.

COVID-19 Analysis:

The rising prevalence of COVID-19 is projected to influence market growth over the forecast period. As the coronavirus outbreak continues, the majority of pharmaceutical companies experienced a significant loss, thereby hampering the microbiology testing market. Revenue losses, temperature checks, emergency loans, and remote working are the new normal for pathology practices in dealing with the COVID-19 pandemic. Lack of testing or inadequate testing has been an issue since the beginning of the outbreak, initially due to the actual absence of authorized tests and later because of a shortage of supplies needed to conduct tests.On the manufacturer's side, a surge in demand for assay reagents, diagnostic kits, equipment, and services has been observed. For instance, Thermo Fisher Scientific predicts COVID-19 testing could create a USD 750 million tailwind in its second-quarter filing. In the first quarter of 2020, its laboratory products and services segment revenue grew 9% to USD 2.73 billion, compared with the revenue of USD 2.51 billion in the first quarter of 2019. Moreover, several policy changes were made owing to the COVID-19. These new government policies in improving the diagnostic and testing processes will eventually lead to the growth of microbiology testing as it is an essential component in the testing of viruses.

Market Dynamics:

Market Drivers

Increasing number of infectious diseases, including COVID-19


According to the WHO, three infectious diseases were ranked in the top ten causes of death worldwide in 2016, including lower respiratory infections, diarrheal diseases, and tuberculosis. Thus, the rising prevalence and incidence of infectious diseases drives the demand for microbiology testing, resulting in the growth of the global market. Moreover, the increasing cases of COVID-19 also contribute to the growth of the market. 


  • Government and private funds andfunding for R&D


Growing government and private funds and support for research and development further drive the growth of the market. For instance,the Department of Science and Technology (DST), India, announced funding of approximately USD 26.42 million to many scientific institutions, startups, and industries to build innovative solutions to fight the COVID-19 pandemicon 8 April 2020. These solutions include rapid and accurate diagnosis kits (paper-based and other point-of-care devices), protection equipment, and other necessary solutions and areanticipated to boost the demand for microbiology testing. 

  • Rising number of approvals and product launches


Several prominent players operating in the market are focusing on getting regulatory approvals and product launches to strengthen their position in the market. For instance, in April 2019, Bruker, an American manufacturer of scientific instruments, launched new assays, software, and library extensions for its MALDI Biotyper, IR Biotyper, and Fluorocycler XT product lines for microbial testing, infection control, and molecular diagnostics of infectious diseases.

Market Restraints


  • Limited reimbursement in developing regions


In most countries, delayed reimbursement acts as a key barrier to market growth. Reimbursement for microbiology testing is a complex process. The complexity in the reimbursement process itself acts as a challenge for this market.Also, the lack of standardized reimbursement policies in different countries limits the growth of the market. Thus, the lack of reimbursement in developing countries hampers market growth.

  • Lack of accuracy of tests


Studies have found that testing kits and devices can show false-negative results.Owing to various reasons, the microbial testing kits often lack accuracy. This lack of accuracy of microbiology testing is anticipated to restraint the growth of the market.

Market Opportunities


  • Collaboration of major players with small players


The global microbiology testing market has numerous well-known players, such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Roche Diagnostics, and Danaher. Apart from these, other players are also actively collaborating with small players to invest in their innovative technologies and launch new infectious disease tests in the market. For instance, CSL Behring, a US biotherapeutics company, and South Dakota-based SAB Therapeutics are working together for clinical trials of its antibody-based treatment SAB-185 on COVID-19 patients. Likewise, the increasing collaboration of major players with small players is anticipated to provide significant growth opportunities for the market. 

Global Microbiology TestingMarketShare, by Product Type, 2019 (%)
Source: MRFR Analysis 

Value Chain Analysis / Technology Analysis / Regulatory Implications

The value chain analysis for the microbiology testing industry comprises five major components that start with the research & product development followed by manufacturing the products, distribution, sales, and post-sales services.The key market players focus on incorporating innovations in their current techniques to keep any discrepancies at bay. For instance, in July 2017, BD (Becton, Dickinson and Company), a leading global medical technology company, launched a new technology that can automatically report and release negative urine cultures.

Segment Overview

The global microbiology testing market has been divided based on product type, type of test, application, and end user.

By product type

  • Consumables


The consumables segment is further segmented into reagents, kits, and others. Chemicals and reagents are crucial elements of any research. Different kinds of chemicals and reagents are used in microbiology testing. Laboratory consumables and accessories like Petri dishes, bottles, containers, PCR consumables, tubes, pipettes, and many others are an essential part of routine laboratory practices.

  • Instruments


The instruments segment is further divided into microbiology analyzers, automated microbiology instruments, and others. Advanced instruments play a very important role in the development and management of microorganisms for research. The instruments include laboratory instruments, microbiology analyzers, and dispensers.By type of testOn the basis of type of test, the market is bifurcated into bacterial, viral, fungal, and others.The bacterial testing type accounts for the largest share and is anticipated to register a CAGR of 9.82% from 2020 to 2027.

  • Bacterial


Bacterial testing type accounts for the largest share due to the increasing prevalence of infections due to bacterial pathogens and the rise in guidelines streamlining the process of Antimicrobial Susceptibility Testing (AST).

  • Viral


Viral infections accounted for a significant share due to the outbreak of coronavirus all over the globe. Owing to the increasing prevalence of viral infection and outbreaks, there is a significant demand forviral infection screening.This drives the growth of the market

  • Fungal


Fungal diseases are often caused by fungi commonly found in the environment. The National Center for Biotechnology Information (NCBI), in 2017, stated that nearly a billion people are estimated to have skin, nail, and hair fungal infections, which have a significant impact on their lives or are fatal.By ApplicationOn the basis of application, the market is segmented into gastrointestinal (GI) infections, respiratory infections, Urinary Tract Infections (UTI), sexually transmitted infections, and others. The gastrointestinal infections segment accounts for the largest share and is projected to reach USD 3,222.42 million by the end of 2027, owing to the increasing number of patients suffering from gastrointestinal infections and rising healthcare expenditure.

  • Gastrointestinal Infections


According to the National Center for Biotechnology Information (NCBI), gastrointestinal infections in the US have consistently been among the most frequent diseases.

  • Respiratory Infections


Respiratory infections are the most common and rapidly growing type of infection. These infections are classified into two major types, i.e., upper and lower acute respiratory infections. Upper acute respiratory diseases are mild and mostly caused by viruses.

  • Urinary Tract Infections


UTI infections are on the rise among young women. For instance, according to the NCBI in 2016, around 50–60% of women are likely to experience a UTI in their lifetime, and the estimated number of UTIs per person per year is 0.5 in young females.

  • Sexually Transmitted Infections


According to the WHO, more than 1 million Sexually Transmitted Infections (STIs) are acquired every day worldwide. This high rate of sexually transmitted infections drives the market growth.  By End UserOn the basis of end user, the market is bifurcated into hospital-associated laboratory, independent laboratory, academic and research institutes, and others. The hospital-associated laboratory segment accounted for the largest market share with a value of USD 1,337.84 million in 2019 due to the increasing inclination toward realizing importance of accurate diagnosis, and testing prompts the demand for microbiology testing in the laboratories.

  • Hospital Associated Laboratory


Hospital-associated laboratories act as a support to the clinical services offered at the hospital. The specific services offered by hospital-associated labs include anatomic (surgical pathology, cytopathology, and autopsy) and clinical (laboratory medicine) testing.

  • Independent Laboratory


Independent laboratories are private and commercial facilities that conduct high volume and also specialty (high complexity and/or rare) laboratory testing. Most of these tests are referred by physicians, hospital facilities, and other patient care facilities such as nursing homes.

  • Academic and Research Institutes


The rise in infectious diseases pushes the demand for testing in academic and research institutes. These institutions are continuously involved in research activity to best diagnose a certain micro-organism.

  • Others


The others segment includes diagnostic centers and path labs affiliated withambulatory centers.

Global Microbiology TestingMarket Share, by Region, 2019 (%)

Source: MRFR Analysis

Regional Analysis

The global microbiology testing market, based on region, has been divided into the

Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas: The Americas is expected to command the largest market share due to a well-developed healthcare sector, rising prevalence and incidence rate of infectious diseases, and the presence of leading players. In addition, the rise in strategic initiatives employed by major players is boosting the demand for microbiology testing in the region. For instance, in April 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., a company based in the US that offers instruments and consumables for the isolation, detection, and analysis of single cells.

Europe:
Europe accounted for a substantial share in the global microbiology testing market.This can be attributed to the increasing support from the government, the presence of a huge geriatric population, and high healthcare spending.Also, the players are partnering up with public and private institutions to create awareness regarding microbiology testing advancements. For instance, in December 2019, BioMérieux (France) was selected as a supplier in a tender process by the Fleming Fund, a USD 333 million (pound 265 million) aid investment to tackle antimicrobial resistance in low middle-income countries around the world.Asia-Pacific:Asia-Pacific is expected to be the fastest-growing market in microbiology testing, mainly due to increasing funding for R&D, developing healthcare infrastructure, increasing awareness about microbiology testing, government initiatives, and support to improve public health and huge investment by companies. Thus, owing to these factors, Asia-Pacific is lucrative for the microbiology testing market.

Middle East & Africa:The microbiology testing market in Middle East & Africa is growing dramatically due to the increasing prevalence of various infectious diseases like Ebola. Moreover, sexually transmitted diseases are also a major public health concern in this region. The Middle East region is growing significantly as compared to Africa. Factors affecting the microbiology testing market in this region are limited access to healthcare facilities, lack of knowledge of new microbiology testing techniques, less funding in R&D, and limited availability of products.

Competitive Landscape

The microbiology testing market is profitable, both for existing players as well as new entrants. A substantial level of rivalry is observed among the existing manufacturers in the market. Our analysis revealed that market players have adopted different strategies and innovative research and development techniques to expand their business and secure their global microbiology testing market position. For instance, in July 2020, bioMérieux launched BIOFIRE MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics (antibodies, hormones, cell and gene therapies, etc.), the most vibrant sector in the pharmaceutical industry. The new BIOFIRE MYCOPLASMA test, which is available in the United States, is expected to be launched in some countries in Europe and the Asia-Pacific region. Furthermore, in May 2020, Beckman Coulter launched DxH 690T hematology analyzer in the U.S. DxH 690T provides all of the benefits of the company’s flagship DxH 900 large-volume hematology analyzer in a table-top configuration. Commercially available worldwide, the DxH 690T builds on Beckman Coulter’s strength and history in hematology innovation and complements its broad hematology portfolioBeckman Coulter, Inc. has the robust industry experienceand is one of the leading companies in the microbiology testing market. Furthermore,a high customer satisfaction level, exceptional performance in new markets, and a strong product portfolio add to the company’s competitive advantage. The company also has a strong clientele and is well established in the industry. Also, it is continuously involved in seminars, conferences, and trade fairs in several countries to generate awareness about its products. Beckman Coulter works as a subsidiary of Danaher Corporation.

List of Key Companies Covered in this report:



  • BioMérieux SA (France)

  • Beckman Coulter, Inc. (US)

  • Bio-Rad Laboratories, Inc. (US)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Merck KGaA(Germany)

  • Thermo Fisher Scientific Inc. (US)

  • Qiagen (Germany)

  • Shimadzu Corporation (Japan)

  • Agilent Technologies Inc. (US)

  • Bruker (US)


Recent Developments

  • In February2020, QIAGEN partnered with Nigeria’s National Tuberculosis & Leprosy Control Program (NTBLCP) to adopt the World Health Organization (WHO) guidelines and guide healthcare professionals in dealing with latent TB

  • In July 2020, bioMérieux launched BIOFIRE MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics (antibodies, hormones, cell and gene therapies, etc.), the most vibrant sector in the pharmaceutical industry. The new BIOFIRE MYCOPLASMA test, which is available in the United States, will be launched in some countries in Europe and the Asia-Pacific region in the coming months

  • In July 2019, Roche announced the Global Access Program in expanding beyond HIV, including mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle-income country programs where the disease burden is found to be the highest. Roche’s commitment to improve access to cost-effective resources, contribute to the elimination of diseases in the regions with the greatest need, and implement scale-up programs reflect in the expansion of the Global Access Program.


 Report Overview: 

The study covers the existing short-term and long-term market effect, helping decision-makers to draught short-term and long-term plans for businesses by region. The report covers major regions in the Americas, Europe, Asia-Pacific, and Middle East & Africa. The report analyzes market drivers, restraints, opportunities, challenges, Porter's Five Forces, Value Chain, and impact of COVID-19 on the market.  

Scope of the Report & Segmentation Global Microbiology Testing Market, by Product Type

  • Consumables

  • Instruments

    • Microbiology Analyzers

    • Automated Microbiology Instruments



  • Others


Global Microbiology Testing Market, by Type of Test

  • Bacterial

  • Viral

  • Fungal

  • Others


Global Microbiology Testing Market, by Application

  • Gastrointestinal Infections

  • Respiratory Infections

  • Urinary Tract Infections

  • Sexually Transmitted Infections

  • Others


Global Microbiology Testing Market, by End User

  • Hospital Associated Laboratory

  • Independent Laboratory

  • Academic and Research Institutes

  • Others


Global Microbiology Testing Market, by Region


  • Americas

    • North America

    • US

    • Canada



  • Latin America

    • Brazil

    • Mexico

    • Rest of Latin America



  • Europe

    • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Eastern Europe

    • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa



TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 17

1.1 MARKET SYNOPSIS 17

2 MARKET INTRODUCTION 18

2.1 DEFINITION 18

2.2 SCOPE OF THE STUDY 18

2.3 RESEARCH OBJECTIVE 18

2.4 MARKET STRUCTURE 18

2.5 ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY 20

3.1 DATA MINING 20

3.2 SECONDARY RESEARCH 20

3.3 PRIMARY RESEARCH 21

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 22

3.5 FORECASTING TECHNIQUES 23

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24

3.6.1 BOTTOM-UP APPROACH 24

3.6.2 TOP-DOWN APPROACH 25

3.7 DATA TRIANGULATION 26

3.8 VALIDATION 26

4 MARKET DYNAMICS 27

4.1 OVERVIEW 27

4.2 DRIVERS 28

4.2.1 INCREASING NUMBER OF INFECTIOUS DISEASES, INCLUDING COVID-19 28

4.2.2 GOVERNMENT AND PRIVATE FUNDS AS WELL AS SUPPORT FOR RESEARCH & DEVELOPMENT 29

4.2.3 RISING NUMBER OF APPROVALS AND PRODUCT LAUNCHES 29

4.3 RESTRAINTS 30

4.3.1 LIMITED REIMBURSEMENT IN DEVELOPING REGIONS 30

4.3.2 LACK OF ACCURACY OF TESTS 30

4.4 OPPORTUNITIES 31

4.4.1 COLLABORATION OF MAJOR PLAYERS WITH SMALL PLAYERS 31

4.4.2 INCORPORATION OF INNOVATION TO THE PRESENT TECHNOLOGY 32

4.5 IMPACT OF COVID-19 ON THE GLOBAL MICROBIOLOGY TESTING MARKET 32

4.5.1 OVERVIEW 32

4.5.2 IMPACT ON CLINICAL TRIALS 32

4.5.3 IMPACT OF MICROBIOLOGY TESTING TO DIAGNOSE COVID-19 33

4.5.4 IMPACT ON TEST VOLUME, REVENUE, AND STAFFING 34

5 MARKET FACTOR ANALYSIS 35

5.1 PORTER’S FIVE FORCES MODEL 35

5.1.1 BARGAINING POWER OF SUPPLIERS 36

5.1.2 BARGAINING POWER OF BUYERS 36

5.1.3 THREAT OF NEW ENTRANTS 36

5.1.4 THREAT OF SUBSTITUTES 36

5.1.5 INTENSITY OF RIVALRY 36

5.2 VALUE CHAIN ANALYSIS 37

5.2.1 R&D AND DESIGNING 38

5.2.2 MANUFACTURING 38

5.2.3 DISTRIBUTION & SALES 38

5.2.4 POST-SALES MONITORING 38

5.3 NUMBER OF ANTIMICROBIAL SUSCEPTIBILITY TESTS (AST) 39

5.3.1 NUMBER OF ANTIMICROBIAL SUSCEPTIBILITY TESTS (AST), BY REGION, 2019 39

5.3.2 NUMBER OF ANTIMICROBIAL SUSCEPTIBILITY TESTS (AST), BY TYPE, 2019 39

5.3.3 NUMBER OF ANTIMICROBIAL SUSCEPTIBILITY TESTS (AST), BY PURPOSE, 2019 39

5.3.4 NUMBER OF ANTIMICROBIAL SUSCEPTIBILITY TESTS (AST), BY SAMPLE TYPE, 2019 39

5.3.5 NUMBER OF ANTIMICROBIAL SUSCEPTIBILITY TESTS (AST), BY LOCATION, 2019 40

5.4 NUMBER OF SPECIES ID TESTS 40

5.4.1 NUMBER OF SPECIES ID, BY REGION, 2019 40

5.4.2 NUMBER OF SPECIES ID, BY TYPE, 2019 40

5.4.3 NUMBER OF SPECIES ID, BY PURPOSE, 2019 40

5.4.4 NUMBER OF SPECIES ID, BY SAMPLE TYPE, 2019 41

5.4.5 NUMBER OF SPECIES ID, BY LOCATION, 2019 41

6 GLOBAL MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE 42

6.1 INTRODUCTION 42

6.2 CONSUMABLES 44

6.3 INSTRUMENTS 44

7 GLOBAL MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST 45

7.1 INTRODUCTION 45

7.2 BACTERIAL 46

7.3 VIRAL 47

7.4 FUNGAL 47

8 GLOBAL MICROBIOLOGY TESTING MARKET, BY APPLICATION 48

8.1 INTRODUCTION 48

8.2 GASTROINTESTINAL INFECTIONS 49

8.3 RESPIRATORY INFECTIONS 50

8.4 URINARY TRACT INFECTIONS 50

8.5 SEXUALLY TRANSMITTED INFECTIONS 51

9 GLOBAL MICROBIOLOGY TESTING MARKET, BY END USER 52

9.1 INTRODUCTION 52

9.2 HOSPITAL ASSOCIATED LABORATORY 53

9.3 INDEPENDENT LABORATORY 54

9.4 ACADEMIC AND RESEARCH INSTITUTES 54

10 GLOBAL MICROBIOLOGY TESTING MARKET, BY REGION 55

10.1 INTRODUCTION 55

10.2 AMERICAS 57

10.2.1 NORTH AMERICA 60

10.2.1.1 US 62

10.2.1.2 CANADA 64

10.2.2 SOUTH AMERICA 66

10.3 EUROPE 69

10.3.1 WESTERN EUROPE 72

10.3.1.1 GERMANY 74

10.3.1.2 FRANCE 76

10.3.1.3 UK 79

10.3.1.4 ITALY 81

10.3.1.5 SPAIN 83

10.3.1.6 REST OF WESTERN EUROPE 85

10.3.2 EASTERN EUROPE 87

10.4 ASIA-PACIFIC 89

10.4.1 CHINA 91

10.4.2 JAPAN 93

10.4.3 INDIA 95

10.4.4 AUSTRALIA 97

10.4.5 SOUTH KOREA 99

10.4.6 REST OF ASIA-PACIFIC 101

10.5 MIDDLE EAST & AFRICA 104

10.5.1 MIDDLE EAST 106

10.5.2 AFRICA 108

11 COMPETITIVE LANDSCAPE 111

11.1 OVERVIEW 111

11.2 COMPETITIVE BENCHMARKING 112

11.3 GLOBAL MICROBIOLOGY TESTING MARKET: COMPANY RANKING 113

11.4 MAJOR GROWTH STRATEGY IN THE GLOBAL MICROBIOLOGY TESTING MARKET 113

11.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 114

11.6 COMPETITIVE BENCHMARKING: GLOBAL MICROBIOLOGY TESTING MARKET 114

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 115

11.7.1 PRODUCT APPROVALS AND LAUNCHES 115

11.7.2 JOINT VENTURES 118

11.7.3 EXPANSIONS 120

11.7.4 ACQUISITIONS 121

12 COMPANY PROFILE 122

12.1 BIO-RAD LABORATORIES, INC. 122

12.1.1 COMPANY OVERVIEW 122

12.1.2 FINANCIAL OVERVIEW 123

12.1.3 PRODUCTS/SERVICES OFFERED 123

12.1.4 KEY DEVELOPMENTS 125

12.1.5 SWOT ANALYSIS 126

12.1.6 KEY STRATEGIES 126

12.2 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORP) 127

12.2.1 COMPANY OVERVIEW 127

12.2.2 FINANCIAL OVERVIEW 128

12.2.3 PRODUCTS/SERVICES OFFERED 128

12.2.4 KEY DEVELOPMENTS 130

12.2.5 SWOT ANALYSIS 132

12.2.6 KEY STRATEGIES 132

12.3 BIOMÉRIEUX SA 133

12.3.1 COMPANY OVERVIEW 133

12.3.2 FINANCIAL OVERVIEW 133

12.3.3 PRODUCTS/SERVICES OFFERED 134

12.3.4 KEY DEVELOPMENTS 135

12.3.5 SWOT ANALYSIS 137

12.3.6 KEY STRATEGIES 137

12.4 THERMO FISHER SCIENTIFIC INC. 138

12.4.1 COMPANY OVERVIEW 138

12.4.2 FINANCIAL OVERVIEW 138

12.4.3 PRODUCTS/SERVICES OFFERED 139

12.4.4 KEY DEVELOPMENTS 140

12.4.5 SWOT ANALYSIS 140

12.4.6 KEY STRATEGIES 141

12.5 F. HOFFMANN-LA ROCHE LTD 142

12.5.1 COMPANY OVERVIEW 142

12.5.2 FINANCIAL OVERVIEW 143

12.5.3 PRODUCTS/SERVICES OFFERED 144

12.5.4 KEY DEVELOPMENTS 144

12.5.5 SWOT ANALYSIS 145

12.5.6 KEY STRATEGIES 145

12.6 QIAGEN 146

12.6.1 COMPANY OVERVIEW 146

12.6.2 FINANCIAL OVERVIEW 147

12.6.3 PRODUCTS/SERVICES OFFERED 147

12.6.4 KEY DEVELOPMENTS 148

12.6.5 SWOT ANALYSIS 149

12.6.6 KEY STRATEGIES 150

12.7 BRUKER 151

12.7.1 COMPANY OVERVIEW 151

12.7.2 FINANCIAL OVERVIEW 152

12.7.3 PRODUCTS/SERVICES OFFERED 152

12.7.4 KEY DEVELOPMENTS 153

12.7.5 SWOT ANALYSIS 153

12.7.6 KEY STRATEGIES 153

12.8 AGILENT TECHNOLOGIES, INC. 154

12.8.1 COMPANY OVERVIEW 154

12.8.2 FINANCIAL OVERVIEW 155

12.8.3 PRODUCTS/SERVICES OFFERED 155

12.8.4 KEY DEVELOPMENTS 156

12.8.5 SWOT ANALYSIS 157

12.8.6 KEY STRATEGIES 157

12.9 SHIMADZU CORPORATION 158

12.9.1 COMPANY OVERVIEW 158

12.9.2 FINANCIAL OVERVIEW 158

12.9.3 PRODUCTS/SERVICES OFFERED 159

12.9.4 KEY DEVELOPMENTS 159

12.9.5 SWOT ANALYSIS 160

12.9.6 KEY STRATEGIES 160

12.10 MERCK KGAA 161

12.10.1 COMPANY OVERVIEW 161

12.10.2 FINANCIAL OVERVIEW 161

12.10.3 PRODUCTS/SERVICES OFFERED 162

12.10.4 KEY DEVELOPMENTS 163

12.10.5 SWOT ANALYSIS 164

12.10.6 KEY STRATEGIES 164

13 APPENDIX 165

13.1 REFERENCES 165

13.2 RELATED REPORTS 165


LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS& LIMITATIONS 19

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22

TABLE 3 NUMBER OF NEW INFECTIOUS DISEASES CASES IN THE US, BY TYPE (2017) 28

TABLE 4 NUMBER OF NEW CASES IN COUNTRIES AFFECTED BY COVID-19 AS OF 14TH JULY 2020 28

TABLE 5 APPROVED TESTS/ASSAYS 33

TABLE 6 GLOBAL MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 42

TABLE 7 GLOBAL MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 43

TABLE 8 GLOBAL MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 43

TABLE 9 GLOBAL MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY REGION, 2017-2027(USD MILLION) 44

TABLE 10 GLOBAL MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY REGION, 2017-2027(USD MILLION) 44

TABLE 11 GLOBAL MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 45

TABLE 12 GLOBAL MICROBIOLOGY TESTING MARKET, FOR BACTERIAL, BY REGION, 2017-2027(USD MILLION) 46

TABLE 13 GLOBAL MICROBIOLOGY TESTING MARKET, FOR VIRAL, BY REGION,2017-2027(USD MILLION) 47

TABLE 14 GLOBAL MICROBIOLOGY TESTING MARKET, FOR FUNGAL, BY REGION,2017-2027(USD MILLION) 47

TABLE 15 GLOBAL MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 48

TABLE 16 GLOBAL MICROBIOLOGY TESTING MARKET, FOR GASTROINTESTINAL INFECTIONS, BY REGION, 2017-2027(USD MILLION) 49

TABLE 17 GLOBAL MICROBIOLOGY TESTING MARKET, FOR RESPIRATORY INFECTIONS, BY REGION,2017-2027(USD MILLION) 50

TABLE 18 GLOBAL MICROBIOLOGY TESTING MARKET, FOR URINARY TRACT INFECTIONS, BY REGION,2017-2027(USD MILLION) 50

TABLE 19 GLOBAL MICROBIOLOGY TESTING MARKET, FOR SEXUALLY TRANSMITTED INFECTIONS, BY REGION,2017-2027(USD MILLION) 51

TABLE 20 GLOBAL MICROBIOLOGY TESTING MARKET, FOR HOSPITAL ASSOCIATED LABORATORY, BY REGION, 2017-2027(USD MILLION) 53

TABLE 21 GLOBAL MICROBIOLOGY TESTING MARKET, FOR INDEPENDENT LABORATORY, BY REGION,2017-2027(USD MILLION) 54

TABLE 22 GLOBAL MICROBIOLOGY TESTING MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION,2017-2027(USD MILLION) 54

TABLE 23 GLOBAL MICROBIOLOGY TESTING MARKET, BY REGION 2017-2027(USD MILLION) 56

TABLE 24 AMERICAS MICROBIOLOGY TESTING MARKET, BY REGION, 2017-2027(USD MILLION) 57

TABLE 25 AMERICAS MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 57

TABLE 26 AMERICAS MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 58

TABLE 27 AMERICAS MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 58

TABLE 28 AMERICAS MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 58

TABLE 29 AMERICAS MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 59

TABLE 30 AMERICAS MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 59

TABLE 31 NORTH AMERICA MICROBIOLOGY TESTING MARKET, BY REGION, 2017-2027(USD MILLION) 60

TABLE 32 NORTH AMERICA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 60

TABLE 33 NORTH AMERICA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027 (USD MILLION) 61

TABLE 34 NORTH AMERICA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 61

TABLE 35 NORTH AMERICA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 61

TABLE 36 NORTH AMERICA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 62

TABLE 37 NORTH AMERICA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 62

TABLE 38 US MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 62

TABLE 39 US MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 63

TABLE 40 US MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 63

TABLE 41 US MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 63

TABLE 42 US MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 64

TABLE 43 US MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 64

TABLE 44 CANADA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 64

TABLE 45 CANADA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 65

TABLE 46 CANADA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 65

TABLE 47 CANADA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 65

TABLE 48 CANADA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 66

TABLE 49 CANADA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 66

TABLE 50 SOUTH AMERICA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 66

TABLE 51 SOUTH AMERICA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 67

TABLE 52 SOUTH AMERICA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 67

TABLE 53 SOUTH AMERICA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 67

TABLE 54 SOUTH AMERICA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 68

TABLE 55 SOUTH AMERICA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 68

TABLE 56 EUROPE MICROBIOLOGY TESTING MARKET, BY REGION, 2017-2027(USD MILLION) 69

TABLE 57 EUROPE MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 69

TABLE 58 EUROPE MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 70

TABLE 59 EUROPE MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 70

TABLE 60 EUROPE MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 70

TABLE 61 EUROPE MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 71

TABLE 62 EUROPE MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 71

TABLE 63 WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY REGION, 2017-2027(USD MILLION) 72

TABLE 64 WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 72

TABLE 65 WESTERN EUROPE MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 73

TABLE 66 WESTERN EUROPE MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 73

TABLE 67 WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 73

TABLE 68 WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 74

TABLE 69 WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 74

TABLE 70 GERMANY MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 74

TABLE 71 GERMANY MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 75

TABLE 72 GERMANY MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 75

TABLE 73 GERMANY MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 75

TABLE 74 GERMANY MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 76

TABLE 75 GERMANY MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 76

TABLE 76 FRANCE MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 76

TABLE 77 FRANCE MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 77

TABLE 78 FRANCE MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 77

TABLE 79 FRANCE MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 77

TABLE 80 FRANCE MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 78

TABLE 81 FRANCE MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 78

TABLE 82 UK MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 79

TABLE 83 UK MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 79

TABLE 84 UK MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 79

TABLE 85 UK MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 80

TABLE 86 UK MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 80

TABLE 87 UK MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 80

TABLE 88 ITALY MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 81

TABLE 89 ITALY MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 81

TABLE 90 ITALY MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 81

TABLE 91 ITALY MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 82

TABLE 92 ITALY MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 82

TABLE 93 ITALY MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 82

TABLE 94 SPAIN MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 83

TABLE 95 SPAIN MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 83

TABLE 96 SPAIN MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 83

TABLE 97 SPAIN MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 84

TABLE 98 SPAIN MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 84

TABLE 99 SPAIN MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 84

TABLE 100 REST OF WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION) 85

TABLE 101 REST OF WESTERN EUROPE MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 85

TABLE 102 REST OF WESTERN EUROPE MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 85

TABLE 103 REST OF WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027 (USD MILLION) 86

TABLE 104 REST OF WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027 (USD MILLION) 86

TABLE 105 REST OF WESTERN EUROPE MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 86

TABLE 106 EASTERN EUROPE MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 87

TABLE 107 EASTERN EUROPE MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027 (USD MILLION) 87

TABLE 108 EASTERN EUROPE MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027 (USD MILLION) 87

TABLE 109 EASTERN EUROPE MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 88

TABLE 110 EASTERN EUROPE MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 88

TABLE 111 EASTERN EUROPE MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 88

TABLE 112 ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2017-2027(USD MILLION) 89

TABLE 113 ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 89

TABLE 114 ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 90

TABLE 115 ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 90

TABLE 116 ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 90

TABLE 117 ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 91

TABLE 118 ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 91

TABLE 119 CHINA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 91

TABLE 120 CHINA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 92

TABLE 121 CHINA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 92

TABLE 122 CHINA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 92

TABLE 123 CHINA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 93

TABLE 124 CHINA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 93

TABLE 125 JAPAN MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 93

TABLE 126 JAPAN MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 94

TABLE 127 JAPAN MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 94

TABLE 128 JAPAN MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 94

TABLE 129 JAPAN MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 95

TABLE 130 JAPAN MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 95

TABLE 131 INDIA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 95

TABLE 132 INDIA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 96

TABLE 133 INDIA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 96

TABLE 134 INDIA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 96

TABLE 135 INDIA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 97

TABLE 136 INDIA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 97

TABLE 137 AUSTRALIA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 97

TABLE 138 AUSTRALIA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 98

TABLE 139 AUSTRALIA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 98

TABLE 140 AUSTRALIA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 98

TABLE 141 AUSTRALIA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 99

TABLE 142 AUSTRALIA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 99

TABLE 143 SOUTH KOREA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 99

TABLE 144 SOUTH KOREA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 100

TABLE 145 SOUTH KOREA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 100

TABLE 146 SOUTH KOREA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 100

TABLE 147 SOUTH KOREA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 101

TABLE 148 SOUTH KOREA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 101

TABLE 149 REST OF ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 101

TABLE 150 REST OF ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 102

TABLE 151 REST OF ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 102

TABLE 152 REST OF ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 102

TABLE 153 REST OF ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 103

TABLE 154 REST OF ASIA-PACIFIC MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 103

TABLE 155 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING MARKET, BY REGION 2017-2027(USD MILLION) 104

TABLE 156 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 104

TABLE 157 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 105

TABLE 158 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 105

TABLE 159 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 105

TABLE 160 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 106

TABLE 161 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 106

TABLE 162 MIDDLE EASTMICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 106

TABLE 163 MIDDLE EASTMICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 107

TABLE 164 MIDDLE EASTMICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 107

TABLE 165 MIDDLE EASTMICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 107

TABLE 166 MIDDLE EASTMICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 108

TABLE 167 MIDDLE EASTMICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 108

TABLE 168 AFRICA MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2017-2027(USD MILLION) 108

TABLE 169 AFRICA MICROBIOLOGY TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2017-2027(USD MILLION) 109

TABLE 170 AFRICA MICROBIOLOGY TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2017-2027(USD MILLION) 109

TABLE 171 AFRICA MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2017-2027(USD MILLION) 109

TABLE 172 AFRICA MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2017-2027(USD MILLION) 110

TABLE 173 AFRICA MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 110

TABLE 174 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MICROBIOLOGY TESTING MARKET 114

TABLE 175 PRODUCT APPROVALS AND LAUNCHES 115

TABLE 176 JOINT VENTURES 118

TABLE 177 EXPANSIONS 120

TABLE 178 ACQUISITIONS 121

TABLE 179 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 123

TABLE 180 BIO-RAD LABORATORIES, INC.: KEY DEVELOPMENTS 125

TABLE 181 BECKMAN COULTER, INC.: PRODUCTS/SERVICES OFFERED 128

TABLE 182 BECKMAN COULTER, INC.: KEY DEVELOPMENTS 130

TABLE 183 BIOMÉRIEUX SA: PRODUCTS/SERVICES OFFERED 134

TABLE 184 BIOMÉRIEUX SA: KEY DEVELOPMENTS 135

TABLE 185 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 139

TABLE 186 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS 140

TABLE 187 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 144

TABLE 188 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 144

TABLE 189 QIAGEN: PRODUCTS/SERVICES OFFERED 147

TABLE 190 QIAGEN: KEY DEVELOPMENTS 148

TABLE 191 BRUKER: PRODUCTS/SERVICES OFFERED 152

TABLE 192 BRUKER: KEY DEVELOPMENTS 153

TABLE 193 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 155

TABLE 194 AGILENT TECHNOLOGIES, INC.: KEY DEVELOPMENTS 156

TABLE 195 SHIMADZU CORPORATION: PRODUCTS/SERVICES OFFERED 159

TABLE 196 SHIMADZU CORPORATION: KEY DEVELOPMENTS 159

TABLE 197 MERCK KGAA: PRODUCTS/SERVICES OFFERED 162

TABLE 198 MERCK KGAA: KEY DEVELOPMENTS 163


LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 17

FIGURE 2 GLOBAL MICROBIOLOGY TESTING MARKET: STRUCTURE 18

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 24

FIGURE 4 MARKET DYNAMICS: GLOBAL MICROBIOLOGY TESTING MARKET 27

FIGURE 5 DRIVERS: IMPACT ANALYSIS 30

FIGURE 6 RESTRAINTS: IMPACT ANALYSIS 31

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MICROBIOLOGY TESTING MARKET 35

FIGURE 8 VALUE CHAIN ANALYSIS OF THE MICROBIOLOGY TESTING MARKET 37

FIGURE 9 GLOBAL MICROBIOLOGY TESTING MARKET, BY PRODUCT TYPE, 2019 & 2027 (USD MILLION) 43

FIGURE 10 GLOBAL MICROBIOLOGY TESTING MARKET, BY TYPE OF TEST, 2019 & 2027 (USD MILLION) 46

FIGURE 11 GLOBAL MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2019 & 2027 (USD MILLION) 49

FIGURE 12 GLOBAL MICROBIOLOGY TESTING MARKET, BY END USER, 2017-2027(USD MILLION) 52

FIGURE 13 GLOBAL MICROBIOLOGY TESTING MARKET, BY END USER, 2019 & 2027 (USD MILLION) 53

FIGURE 14 GLOBAL MICROBIOLOGY TESTING MARKET SHARE, BY REGION 2019 (%) 56

FIGURE 15 AMERICAS MICROBIOLOGY TESTING MARKET SHARE, BY REGION, 2019 (%) 57

FIGURE 16 NORTH AMERICA MICROBIOLOGY TESTING MARKET SHARE, BY REGION, 2019 (%) 60

FIGURE 17 EUROPE MICROBIOLOGY TESTING MARKET SHARE, BY COUNTRY/REGION, 2019 (%) 69

FIGURE 18 WESTERN EUROPE MICROBIOLOGY TESTING MARKET SHARE, BY COUNTRY/REGION, 2019 (%) 72

FIGURE 19 ASIA-PACIFIC MICROBIOLOGY TESTING MARKET SHARE, BY COUNTRY/REGION, 2019 (%) 89

FIGURE 20 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING MARKET SHARE, BY COUNTRY/REGION, 2019 (%) 104

FIGURE 21 BENCHMARKING OF MAJOR COMPETITORS 112

FIGURE 22 MAJOR MANUFACTURERS RANKING, 2019 113

FIGURE 23 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL MICROBIOLOGY TESTING MARKET 113

FIGURE 24 COMPETITIVE BENCHMARKING 114

FIGURE 25 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 26 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS 126

FIGURE 27 BECKMAN COULTER, INC.: FINANCIAL OVERVIEW SNAPSHOT 128

FIGURE 28 BECKMAN COULTER, INC.: SWOT ANALYSIS 132

FIGURE 29 BIOMÉRIEUX SA: FINANCIAL OVERVIEW SNAPSHOT 133

FIGURE 30 BIOMÉRIEUX SA: SWOT ANALYSIS 137

FIGURE 31 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 138

FIGURE 32 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 140

FIGURE 33 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 143

FIGURE 34 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 145

FIGURE 35 QIAGEN: FINANCIAL OVERVIEW 147

FIGURE 36 QIAGEN: SWOT ANALYSIS 149

FIGURE 37 BRUKER: FINANCIAL OVERVIEW SNAPSHOT 152

FIGURE 38 BRUKER: SWOT ANALYSIS 153

FIGURE 39 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW 155

FIGURE 40 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS 157

FIGURE 41 SHIMADZU CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 158

FIGURE 42 SHIMADZU CORPORATION: SWOT ANALYSIS 160

FIGURE 43 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 161

FIGURE 44 MERCK KGAA: SWOT ANALYSIS 164



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Microbiology Testing Market